News & Media :: Vedanta Biosciences, Inc.

Sep 23, 2019

Vedanta Biosciences Announces $16.6 Million Series C-2 Financing

Recent News

Aug 27, 2019

Voice of America Episode: Defined Bacterial Consortia for Prevention of CDI Recurrence

Jul 1, 2019

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food Allergy Clinical Study

Jun 25, 2019

Vedanta Biosciences’ Silvia Caballero, Ph.D., Named as an MIT Technology Review Global Innovator Under 35

May 23, 2019

Microbiome therapies could be the next frontier in medicine. But how exactly do you make them?

View All News View All Press Releases